| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/13/2006 | WO2006033698A3 Tissue matrix system |
| 07/13/2006 | WO2006026555A3 Neuroprotective effect of solubilized udca in focal ischemic model |
| 07/13/2006 | WO2006016020A3 Nanoparticles comprising a core essentially consisting of a cyanoacrylic polymer and a shell of an amphiphilic polymer and, optionally, an active principle, preferably bisulfan |
| 07/13/2006 | WO2006005287A3 Capsule for releasing agents contained therein at defined points in a body |
| 07/13/2006 | WO2006002195A3 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 07/13/2006 | WO2005117833A3 Methods for dose selection of liposomal encapsulated sn38 |
| 07/13/2006 | WO2005110364A3 Drug delivery systems and methods for treatment of an eye |
| 07/13/2006 | WO2005107735A3 Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a |
| 07/13/2006 | WO2005102288A3 Lozenge for delivery of dextromethorphan |
| 07/13/2006 | WO2005084710A3 Nanocell drug delivery system |
| 07/13/2006 | WO2005082006A3 Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom |
| 07/13/2006 | WO2005074990A3 Methods of preventing and treating sars using low ph respiratory tract compositions |
| 07/13/2006 | WO2005067503A3 Confection product containing urea |
| 07/13/2006 | WO2005065656A3 Stabilized pharmaceutical solid compositions of low-solubility drugs, poloxamers, and stabilizing polymers |
| 07/13/2006 | WO2005046640A3 Multi-site drug delivery platform |
| 07/13/2006 | WO2005046582A3 Polymeric interpenetrated network carrier and serial polymerization involving a crosslinked polymer network |
| 07/13/2006 | WO2005023330A3 Pharmaceutical metered dose inhaler and methods relating thereto |
| 07/13/2006 | WO2004010842A3 Lipophilic electrophoretic probes |
| 07/13/2006 | US20060155301 Methods and devices usable in eye surgery |
| 07/13/2006 | US20060155251 Disposable pharmaceutical or cosmetic product applicator |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155108 Multiple branch peptide construction |
| 07/13/2006 | US20060155101 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 07/13/2006 | US20060155047 Adhesive tape and substrate for adhesive tape |
| 07/13/2006 | US20060154910 Use of steroids to treat ocular disorders |
| 07/13/2006 | US20060154901 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 07/13/2006 | US20060154900 Diphosphonate solutions |
| 07/13/2006 | US20060154898 Diphosphonate solutions |
| 07/13/2006 | US20060154893 Exopolysaccharides delivery system for active molecules |
| 07/13/2006 | US20060154871 Peptides |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060154867 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | US20060153930 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 07/13/2006 | US20060153925 Novel solid pharmaceutical composition comprising amisulpride |
| 07/13/2006 | US20060153924 Selection by compartmentalised screening |
| 07/13/2006 | US20060153923 Nanoparticles of polypoxyethylenated derivatives |
| 07/13/2006 | US20060153922 Light induced immobilisation |
| 07/13/2006 | US20060153921 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions |
| 07/13/2006 | US20060153920 Lyophilized pharmaceutical compositions |
| 07/13/2006 | US20060153919 Ligand-mediated controlled drug delivery |
| 07/13/2006 | US20060153918 Dosage forms with an enterically coated core tablet |
| 07/13/2006 | US20060153917 Enteric coated bead comprising ixabepilone, and preparation and administration thereof |
| 07/13/2006 | US20060153916 Novel dosage form |
| 07/13/2006 | US20060153915 Sustained-release preparations and method for producing the same |
| 07/13/2006 | US20060153914 Treating or preventing myocardial ischemia and angina pectoris; time-release Galenical preparation |
| 07/13/2006 | US20060153913 Solid formulation with improved solubility and stability, and method for producing said formulation |
| 07/13/2006 | US20060153912 Choline ascorbate formulations |
| 07/13/2006 | US20060153911 Method for preserving reduced coenzyme Q10 |
| 07/13/2006 | US20060153909 Hard capsule |
| 07/13/2006 | US20060153908 Spherical pellet formulations |
| 07/13/2006 | US20060153907 Liposome formulations of boronic acid compounds |
| 07/13/2006 | US20060153906 Pharmaceutical product for endonasal administration for treating central nervous system disease and disorders |
| 07/13/2006 | US20060153905 Analgesic, Parkinson or Alzheimer drug in a solvent system containing a monoalkyl ether of diethylene glycol, a glycol, and a mixture of a C2 to C4 alcohol and water; inhibits crystallization and transfer to clothing, improves and modulates bioavailability within skin layers; nonocclusive, semi-solid |
| 07/13/2006 | US20060153900 Dietary supplement for treatment of lipid risk factors |
| 07/13/2006 | US20060153898 Orally administering to a human subject in need thereof, just prior to nighttime sleep, from about 10 grams to about 250 grams of a muscle growth enhancing mixture, the mixture comprising:nutritional food proteins selected from milk proteins, whey protein, wheat protein, soy protein |
| 07/13/2006 | US20060153885 Dry eye treatment |
| 07/13/2006 | US20060153863 Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's |
| 07/13/2006 | US20060153858 Drug delivery of a liquid comprising an antigen such as tumor-associated antigen directly to an area of high lymphatic drainage or a lymphatic system of the mammal to induce an antigen-specific Cytotoxic T lymphocyte (CTL) response; sustained release |
| 07/13/2006 | US20060153848 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/13/2006 | US20060153846 Formulation of human antibodies for treating tnf-alpha associated disorders |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153826 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 07/13/2006 | US20060153804 Nucleic acid coated particles |
| 07/13/2006 | US20060153793 Aqueous polymer dispersion and use thereof in cosmetics |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060153778 Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| 07/13/2006 | US20060153771 Preparations for measuring gastric emptying ability |
| 07/13/2006 | US20060153757 Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid |
| 07/13/2006 | US20060151900 solid (cyclosporine, gemfibrozil or fenofibrate) melts under pressure of gas without degrading at temperature lower than melting point, forming solution with carrier, passing through vessel of lower pressure to form particles; encapsulated with biodegradable polyoxyethylene glycol, cellulose acetate |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | CA2594363A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | CA2594332A1 Nanoparticulate candesartan formulations |
| 07/13/2006 | CA2594273A1 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 07/13/2006 | CA2594087A1 Plastic bottle for oxaliplatin solution |
| 07/13/2006 | CA2594065A1 Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion |
| 07/13/2006 | CA2593593A1 Sustained release pharmaceutical formulations comprising ranolazine |
| 07/13/2006 | CA2593562A1 Non-irritating compositions containing zinc salts |
| 07/13/2006 | CA2593549A1 Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
| 07/13/2006 | CA2593394A1 Preparation for preventing or treating calcium deficiency conditions in mammals |
| 07/13/2006 | CA2593094A1 Controlled long acting release pharmaceutical preparation for use in the oral cavity |
| 07/13/2006 | CA2593019A1 Compositions and methods relating to novel compounds and targets thereof |
| 07/13/2006 | CA2592978A1 Topical stabilized prostaglandin e compound dosage forms |
| 07/13/2006 | CA2591995A1 Anti-itch cloth for women |
| 07/12/2006 | EP1679085A2 Pressure-sensitive adhesive sheet for application to skin |
| 07/12/2006 | EP1679084A1 X-ray contrast medium containing liposome and method for preparation thereof |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1679075A1 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 07/12/2006 | EP1679066A1 Drug-containing coated microparticle for orally disintegrating tablet |
| 07/12/2006 | EP1679065A1 Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1679063A1 Novel liquid preparation composition |
| 07/12/2006 | EP1678476A2 Method to fabricate microcapsules from polymers and charged nanoparticles |
| 07/12/2006 | EP1678104A1 Process for producing 1-octene from butadiene in the presence of titanium catalysts |
| 07/12/2006 | EP1678103A1 Process for the preparation of 1-octene |
| 07/12/2006 | EP1677828A1 Composite material comprising a porous semiconductor impregnated with an organic substance |
| 07/12/2006 | EP1677823A1 Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| 07/12/2006 | EP1677818A1 Stable aqueous g-csf-containing compositions |
| 07/12/2006 | EP1677812A2 Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
| 07/12/2006 | EP1677811A1 Medicament on the basis of honey, preparation and use thereof |